Tag: SHP2 Inhibition
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Co-lending needs greater parity amid heightened regulatory scrutiny, argues Nishant Kotak, head of legal at DSP Group